Aseptika Ltd


Support clinicians to deliver “blended” healthcare services (hybrid delivery) of in-person and video consultations, supported with digital remote monitoring and digital patient education to improve health outcomes, reduce the burden on clinical staff and enable a safe increase in the ratio of patients to clinical staff.

Certified as a Class I medical device (CE and UKCA marked). Developed to ISO 13485:2016.

Asthma+me: Hybrid care for Children and Young People with severe asthma at risk of hospitalisation from a further asthma attack. Includes: Spirometer, Smart Inhaler trackers, Asthma+me App, clinically reviewed education programmes for both Children and Young People and their adult Parents or Carers.
Active+me REMOTE Cardiac Rehabilitation and Heart Failure. Two dedicated hybrid delivery programmes for patients following a cardiac event and separately, long-term support of patients with Heart Failure. Includes Remote monitoring, video consultations, pre-recorded and live delivery of exercise classes, a paced-walking programme and the ability for patients to track levels of breathlessness or exertion.
Active+me REMOTE for Pulmonary Rehabilitation. Designed to support patients at any stage of their rehabilitation for respiratory disease. Includes patient-level alerts, symptom tracking, changes in physiological signs and adherence to medication with smart inhaler trackers.

Key Facts

Hybrid Cardiac Rehabilitation delivered during the pandemic using the Active+me REMOTE product achieved: – Increase in Patient Activation Scores from 65.5 at baseline to 70.2 (greatest increase from 61.9 to 75.0 in High-Risk groups). – Reduction in resting systolic blood pressure by 6mmHg. – Decrease in waist circumference by 7.5 cm. – Increase in self-reported physical activity. – Completion of the programme with Active+me REMOTE was 93.4% (in-person UK completion rate 77% nationally).

Successes in UK/NHS

Our products and platforms are now used in 8 NHS hospitals in the UK. Results from a real-world evaluation at Cambridge's Addenbrookes Hospital have been published in a peer-reviewed journal (December 2021).

Company details


Delivering advanced patient care


Digitally-enabled out of hospital care

Long-term condition monitoring

Company details

Want to connect with this innovator?

Make an enquiry

Markets already exporting to

Ireland Brazil

Desired Markets

Australia, Canada, EU, New Zealand, USA.

Desired customer types

Hospitals, government health systems and private groups.

Want to connect with this innovator?
Make an enquiry
This field is required
This field is required
This field is required
This field is required
This field is required

Thank you

We are processing your request and will return your contact as soon as possible.